data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italian
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italian
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
InMed Pharmaceuticals
(NASDAQ:INM)
0.76
00
Last update: 4:00PM
15 minutes delayed
Day High/Low- - -
52 Week High/Low0.65 - 3.51
Open / Close- / -
Float / Outstanding14.6M / 14.6M
Vol / Avg.- / 207.7K
Mkt Cap11.1M
P/E-
50d Avg. Price0.87
Div / Yield-
Payout Ratio-
EPS-0.25
Total Float14.6M

InMed Pharmaceuticals (NASDAQ:INM), Quotes and News Summary

InMed Pharmaceuticals (NASDAQ: INM)

Day High/Low- - -
52 Week High/Low0.65 - 3.51
Open / Close- / -
Float / Outstanding14.6M / 14.6M
Vol / Avg.- / 207.7K
Mkt Cap11.1M
P/E-
50d Avg. Price0.87
Div / Yield-
Payout Ratio-
EPS-0.25
Total Float14.6M
Benzinga - May 17, 2022, 1:49PM
Benzinga - May 13, 2022, 2:13PM
Benzinga - May 13, 2022, 7:37AM
Benzinga - Apr 28, 2022, 7:34AM
Benzinga - Sponsored
Benzinga - Apr 21, 2022, 7:34AM
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Mar 17, 2022, 7:35AM
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Jan 19, 2022, 7:36AM
Benzinga - Jan 7, 2022, 6:52AM
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Dec 20, 2021, 7:34AM
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Sponsored
load more
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.250
REV309.585K
Q2 2022Est.ActualSurprise
EPS-0.230-0.310 -0.0800
REV120.000K265.092K145.092K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

InMed Pharmaceuticals Questions & Answers

Q
How do I buy InMed Pharmaceuticals (INM) stock?
A

You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are InMed Pharmaceuticals's (INM) competitors?
A

There are no as such competitors for InMed Pharmaceuticals.

Q
What is the target price for InMed Pharmaceuticals (INM) stock?
A

The latest price target for InMed Pharmaceuticals (NASDAQ: INM) was reported by HC Wainwright & Co. on Monday, November 29, 2021. The analyst firm set a price target for 6.00 expecting INM to rise to within 12 months (a possible 689.47% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for InMed Pharmaceuticals (INM)?
A

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $0.76 last updated May 25, 2022, 8:00 PM UTC.

Q
Does InMed Pharmaceuticals (INM) pay a dividend?
A

There are no upcoming dividends for InMed Pharmaceuticals.

Q
When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?
A

InMed Pharmaceuticals’s Q3 earnings are confirmed for Friday, May 13, 2022.

Q
Is InMed Pharmaceuticals (INM) going to split?
A

There is no upcoming split for InMed Pharmaceuticals.

Q
What sector and industry does InMed Pharmaceuticals (INM) operate in?
A

InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.